Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.63.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.63.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.63.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.63.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GJ.1.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
FL.33.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.33.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.33.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.33.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.4.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.4.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.4.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JJ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JJ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HN.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.2.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.1.2.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GJ.1.2.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
HK.3.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HK.3.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.6.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.6.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.6.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.6.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FD.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used